These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 27015219)

  • 1. CT, MRI, and 18F-FDG PET/CT Findings in Untreated Pulmonary and Hepatic B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Over a Five-Year Period: A Case Report.
    Dong A; Xiao Z; Yang J; Zuo C
    Medicine (Baltimore); 2016 Mar; 95(12):e3197. PubMed ID: 27015219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary mucosa-associated lymphoid tissue lymphoma: computed tomography and ¹⁸F fluorodeoxyglucose-positron emission tomography/computed tomography imaging findings and follow-up.
    Zhang WD; Guan YB; Li CX; Huang XB; Zhang FJ
    J Comput Assist Tomogr; 2011; 35(5):608-13. PubMed ID: 21926857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary mucosa-associated lymphoid tissue lymphoma:
    Albano D; Borghesi A; Bosio G; Bertoli M; Maroldi R; Giubbini R; Bertagna F
    Br J Radiol; 2017 Nov; 90(1079):20170311. PubMed ID: 28830222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in primary hepatic mucosa-associated lymphoid tissue lymphoma: A case report and review of the literature.
    Bao C; Wei J; Zhao X; Lin L; Chen D; Liu K; Qian W; Anas JM; Zhao K
    Medicine (Baltimore); 2018 Mar; 97(10):e9877. PubMed ID: 29517697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis.
    Treglia G; Zucca E; Sadeghi R; Cavalli F; Giovanella L; Ceriani L
    Hematol Oncol; 2015 Sep; 33(3):113-24. PubMed ID: 25047160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET/CT finding of bilateral primary breast mucosa-associated lymphoid tissue lymphoma.
    Kim DH; Jeong JY; Lee SW; Lee J; Ahn BC
    Clin Nucl Med; 2015 Feb; 40(2):e148-9. PubMed ID: 25140550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-Fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in 18F-FDG avidity according to site involvement.
    Park SH; Lee JJ; Kim HO; Lee DY; Suh C; Jung HY; Choi KD; Kim DH; Huh J; Ryu JS
    Leuk Lymphoma; 2015; 56(12):3288-94. PubMed ID: 25804932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosa-associated lymphoid tissue lymphoma studied with FDG-PET: a comparison with CT and endoscopic findings.
    Enomoto K; Hamada K; Inohara H; Higuchi I; Tomita Y; Kubo T; Hatazawa J
    Ann Nucl Med; 2008 May; 22(4):261-7. PubMed ID: 18535876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET/CT and primary hepatic MALT: a case series.
    Albano D; Giubbini R; Bertagna F
    Abdom Radiol (NY); 2016 Oct; 41(10):1956-9. PubMed ID: 27259334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?: Observations in a Series of 13 Patients.
    Mayerhoefer ME; Giraudo C; Senn D; Hartenbach M; Weber M; Rausch I; Kiesewetter B; Herold CJ; Hacker M; Pones M; Simonitsch-Klupp I; Müllauer L; Dolak W; Lukas J; Raderer M
    Clin Nucl Med; 2016 Feb; 41(2):101-5. PubMed ID: 26402137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET/CT for staging and response assessment of primary parotid MALT lymphoma with multiple sites involvement: A case report.
    Ren Y; Huang L; Han Y; Cui Z; Li J; Dong C; Liu J
    Medicine (Baltimore); 2019 Feb; 98(5):e14270. PubMed ID: 30702589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.
    Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Pinker-Domenig K; Berzaczy D; Hoffmann M; Sillaber C; Jaeger U; Müllauer L; Simonitsch-Klupp I; Dolak W; Gaiger A; Ubl P; Lukas J; Raderer M
    Clin Cancer Res; 2014 Jun; 20(11):2984-93. PubMed ID: 24696320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F-18 FDG PET/CT evaluation of radiotherapy response in rare case of mucosa-associated lymphoid tissue lymphoma.
    Minamimoto R; Tateishi U; Tomita N; Inayama Y; Omura-Minamisawa M; Tayama Y; Hata M; Kubota Y; Inoue T
    Ann Nucl Med; 2010 Feb; 24(2):115-9. PubMed ID: 20077163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Positron Emission Tomography/Computed Tomography in Gastric Mucosa-associated Lymphoid Tissue Lymphoma.
    Hwang JW; Jee SR; Lee SH; Kim JH; Seol SY; Lee SM
    Korean J Gastroenterol; 2016 Apr; 67(4):183-8. PubMed ID: 27112244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.
    Mayerhoefer ME; Karanikas G; Kletter K; Kiesewetter B; Weber M; Rausch I; Pones M; Simonitsch-Klupp I; Müllauer L; Dolak W; Lukas J; Raderer M
    Clin Nucl Med; 2016 Nov; 41(11):837-843. PubMed ID: 27648705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of baseline
    Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F
    Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma.
    Dong A; Dong H; Wang Y; Gong J; Lu J; Zuo C
    Clin Nucl Med; 2013 Feb; 38(2):e66-73. PubMed ID: 22996250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma.
    Perry C; Herishanu Y; Metzer U; Bairey O; Ruchlemer R; Trejo L; Naparstek E; Sapir EE; Polliack A
    Eur J Haematol; 2007 Sep; 79(3):205-9. PubMed ID: 17662066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference.
    Hoffmann M; Wöhrer S; Becherer A; Chott A; Streubel B; Kletter K; Raderer M
    Ann Oncol; 2006 Dec; 17(12):1761-5. PubMed ID: 16980600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.